These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24421157)

  • 21. Regulatory requirements for therapeutic proteins: the relationship between the conformation and biological activity of filgrastim.
    Bristow AF; Bird C; Bolgiano B; Thorpe R
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():103-17. PubMed ID: 23327895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic development.
    Banks DD; Zhang J; Siska CC
    Mol Pharm; 2014 Oct; 11(10):3431-42. PubMed ID: 25144791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adsorption of monoclonal antibodies to glass microparticles.
    Hoehne M; Samuel F; Dong A; Wurth C; Mahler HC; Carpenter JF; Randolph TW
    J Pharm Sci; 2011 Jan; 100(1):123-32. PubMed ID: 20575075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High throughput thermostability screening of monoclonal antibody formulations.
    He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
    J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of granulocyte colony-stimulating factor and structurally analogous growth factors by anionic phospholipids.
    Rourke AM; Cha Y; Collins D
    Biochemistry; 1996 Sep; 35(36):11913-7. PubMed ID: 8794774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preformulation study of highly purified inactivated polio vaccine, serotype 3.
    Qi W; Zeng Y; Orgel S; Francon A; Kim JH; Randolph TW; Carpenter JF; Middaugh CR
    J Pharm Sci; 2014 Jan; 103(1):140-51. PubMed ID: 24282078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development.
    Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS
    J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low temperature thermal dependent Filgrastim adsorption behavior detected with ToF-SIMS.
    Kempson IM; Chang P; Bremmell K; Prestidge CA
    Langmuir; 2013 Dec; 29(50):15573-8. PubMed ID: 24274767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC; Troiber C; Küchler S; Wagner E; Friess W
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of rhbFGF as determined by UV spectroscopic measurements of turbidity.
    Eberlein GA; Stratton PR; Wang YJ
    PDA J Pharm Sci Technol; 1994; 48(5):224-30. PubMed ID: 8000895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular permutation of granulocyte colony-stimulating factor.
    Feng Y; Minnerly JC; Zurfluh LL; Joy WD; Hood WF; Abegg AL; Grabbe ES; Shieh JJ; Thurman TL; McKearn JP; McWherter CA
    Biochemistry; 1999 Apr; 38(14):4553-63. PubMed ID: 10194377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.
    Roberts CJ; Darrington RT; Whitley MB
    J Pharm Sci; 2003 May; 92(5):1095-111. PubMed ID: 12712430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations.
    Di Tommaso C; Como C; Gurny R; Möller M
    Eur J Pharm Sci; 2010 Apr; 40(1):38-47. PubMed ID: 20184955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of protein stability in rod-insert vaginal rings.
    Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
    Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the fluorescence red edge effect to assess the long-term stability of lyophilized protein formulations.
    Qian KK; Grobelny PJ; Tyagi M; Cicerone MT
    Mol Pharm; 2015 Apr; 12(4):1141-9. PubMed ID: 25786057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.
    Aubin Y; Hodgson DJ; Thach WB; Gingras G; Sauvé S
    Pharm Res; 2015 Oct; 32(10):3365-75. PubMed ID: 26043856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.
    Chi EY; Krishnan S; Kendrick BS; Chang BS; Carpenter JF; Randolph TW
    Protein Sci; 2003 May; 12(5):903-13. PubMed ID: 12717013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.